AAP
GMED icon

Arax Advisory Partners’s Globus Medical GMED Stock Holding History

Arax Advisory Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$327K Buy
3,793
+887
+31% +$79.6K 0.01% 829
2025
Q4 		$254K Sell
2,906
-3,046
-51% -$231K 0.01% 922
2025
Q3 		$341K Buy
5,952
+5,770
+3,170% +$332K ﹤0.01% 1055
2025
Q2 		$11K Buy
182
+160
+727% +$10.3K ﹤0.01% 1914
2025
Q1 		$1.61K Sell
22
-134
-86% -$11.1K ﹤0.01% 2139
2024
Q4 		$12.9K Hold
156
– – ﹤0.01% 1396
2024
Q3 		$11.2K Sell
156
-10
-6% -$706 ﹤0.01% 1359
2024
Q2 		$11.4K Buy
166
+158
+1,975% +$9.44K ﹤0.01% 1207
2024
Q1 		$430 Hold
8
– – ﹤0.01% 1243
2023
Q4 		$427 Sell
8
-14
-64% -$682 ﹤0.01% 1234
2023
Q3 		$1.09K Hold
22
– – ﹤0.01% 1107
2023
Q2 		$1.31K Buy
22
+4
+22% +$228 ﹤0.01% 1059
2023
Q1 		$1.02K Sell
18
-315
-95% -$20.2K ﹤0.01% 1097
2022
Q4 		$24.7K Buy
333
+108
+48% +$7.35K ﹤0.01% 538
2022
Q3 		$13K Sell
225
-10
-4% -$602 ﹤0.01% 625
2022
Q2 		$13K Buy
235
+201
+591% +$13.2K ﹤0.01% 616
2022
Q1 		$3K Sell
34
-7
-17% -$487 ﹤0.01% 878
2021
Q4 		$3K Buy
41
+23
+128% +$1.67K ﹤0.01% 839
2021
Q3 		$1K Buy
+18
New +$1.45K ﹤0.01% 906

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arax Advisory Partners's GMED Position: Q1 2026 in Review

Arax Advisory Partners increased its Globus Medical (GMED) stake by 31% in Q1 2026, buying an estimated $79.6K and bringing the position to 3,793 shares worth $327K. The position accounts for 0.01% of the portfolio, ranked #829.

Arax Advisory Partners first reported a position in GMED in Q3 2021 and has held it in 19 quarters since. The position peaked at $341K in Q3 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Arax Advisory Partners held 3,793 shares of Globus Medical worth $327K as of Q1 2026.
  • Arax Advisory Partners bought 887 Globus Medical shares in Q1 2026, an estimated $79.6K.
  • Globus Medical made up 0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #829 holding.
  • Arax Advisory Partners first reported a position in Globus Medical in Q3 2021 and has held it in 19 quarters since.
  • Arax Advisory Partners's Globus Medical position peaked at $341K in Q3 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.